Semiconductor-based Sequencing for Cancer Diagnostics: Gambling with Chips
Christopher Corless, MD, PhD, is the chief medical officer at the Knight Diagnostic Laboratories at Oregon Health & Sciences
University. Dr. Corless discusses results from recent work with the Ion AmpliSeq™ Cancer Panel, comparing its amplicon-based approach to hybrid capture methods. During a presentation at the Association of Molecular Pathology annual meeting in Grapevine, Texas in November. Dr. Corless reviews read depth, sensitivity, hroughput, read length, and accuracy.
Link to this comment:
All Comments (0)